Home
Market
Seagen loses arbitration ruling against Daiichi Sankyo
Market

Seagen loses arbitration ruling against Daiichi Sankyo

2 years ago No Comments

This post was originally published on this site

A Texas jury in April awarded Seagen nearly $42 million from Daiichi Sankyo over claims that Daiichi and AstraZeneca (NASDAQ:AZN) plc’s breast-cancer drug Enhertu violated Seagen’s patent rights.

Related Posts

About The Author

admin
More from this Author